DarioHealth
$8.4
15
+$0.3+3.7% Thursday 20:00
Statistics
Day High
8.4
Day Low
8.01
52W High
17.74
52W Low
5.94
Volume
6,500
Avg. Volume
13,822
Mkt Cap
56.85M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
20MayExpected
Expected EPS
-1.296667
Actual EPS
N/A
Financials
-151.56%Profit Margin
Unprofitable54.08MRevenue
-81.96MNet Income
Analyst Ratings
$10.00Average Price Target
The highest estimate is 10.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow DRIO. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Teladoc Health
TDOC
Mkt Cap1.53B
Dexcom
DXCM
Mkt Cap22.71B
Tandem Diabetes Care
TNDM
Mkt Cap945.97M
Insulet
PODD
Mkt Cap22.03B
Medtronic
MDT
Mkt Cap116.33B
Abbott Laboratories
ABT
Mkt Cap214.96B
Omnicell
OMCL
Mkt Cap1.54B
Koninklijke Philips N.V.
PHG
Mkt Cap26.17B
Masimo
MASI
Mkt Cap7.64B
Smith & Nephew
SNN
Mkt Cap15.61B
About
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Show more...
CEO
Mr. Erez Raphael
Employees
196
Country
US
ISIN
US23725P3082
Listings
0 Comments
Share your thoughts
FAQ
What is DarioHealth stock price today?▼
The current price of DRIO is $8.4 USD — it has increased by +3.7% in the past 24 hours. Watch DarioHealth stock price performance more closely on the chart.
What is DarioHealth stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange DarioHealth stocks are traded under the ticker DRIO.
Is DarioHealth stock price growing?▼
DRIO stock has risen by +3.58% compared to the previous week, the month change is a -15.92% fall, over the last year DarioHealth has showed a -25% decrease.
What is DarioHealth market cap?▼
Today DarioHealth has the market capitalization of 56.85M
When is the next DarioHealth earnings date?▼
DarioHealth is going to release the next earnings report on May 20, 2026.
What were DarioHealth earnings last quarter?▼
DRIO earnings for the last quarter are -0.76 USD per share, whereas the estimation was -3.24 USD resulting in a +76.56% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is DarioHealth revenue for the last year?▼
DarioHealth revenue for the last year amounts to 54.08M USD.
What is DarioHealth net income for the last year?▼
DRIO net income for the last year is -81.96M USD.
How many employees does DarioHealth have?▼
As of April 05, 2026, the company has 196 employees.
In which sector is DarioHealth located?▼
DarioHealth operates in the Health Care sector.
When did DarioHealth complete a stock split?▼
The last stock split for DarioHealth was on August 28, 2025 with a ratio of 1:20.
Where is DarioHealth headquartered?▼
DarioHealth is headquartered in New York, US.